https://news.medxy.ai/zh/hip-projection-technology/Medxy AIzh2026-09-30T07:18:36-07:00新型滑动性脂肪筋膜瓣技术可增强下半身提升术中的髋部投影 https://news.medxy.ai/ja/79600-2/Medxy AIja2026-09-30T07:18:20-07:00新型スライディング脂肪筋膜弁法は、下半身リフト術における股関節部の突出感を増強できる https://news.medxy.ai/vi/adipofascial-flap-technique/Medxy AIvi2026-09-30T07:17:59-07:00Kỹ thuật vạt adipofascial trượt đổi mới giúp tăng độ nhô hông trong phẫu thuật nâng thân dưới https://news.medxy.ai/innovative-sliding-adipofascial-flap-technique-enhances-hip-projection-in-lower-body-lift-surgery/Medxy AIen2026-09-30T07:17:40-07:00Innovative Sliding Adipofascial Flap Technique Enhances Hip Projection in Lower Body Lift Surgery https://news.medxy.ai/zh/latissimus-dorsi-flap-2/Medxy AIzh2026-09-30T07:17:04-07:00背阔肌供区可否再用？保留肌肉皮瓣为假体乳房重建失败提供二次挽救方案 https://news.medxy.ai/ja/79591-2/Medxy AIja2026-09-30T07:16:48-07:00広背筋採取部位の再利用は可能か？――筋皮弁の温存が、インプラントによる乳房再建失敗時の二次的救済策となる https://news.medxy.ai/vi/latissimus-dorsi-flap/Medxy AIvi2026-09-30T07:16:29-07:00Tái xét vị trí cho vạt cơ lưng rộng: Vạt bảo tồn cơ mở ra khả năng cứu vãn lặp lại trong thất bại tái tạo vú bằng túi độn https://news.medxy.ai/revisiting-the-latissimus-dorsi-donor-site-muscle-sparing-flap-offers-repeat-salvage-option-in-implant-based-breast-reconstruction-failures/Medxy AIen2026-09-30T07:16:12-07:00Revisiting the Latissimus Dorsi Donor Site: Muscle-Sparing Flap Offers Repeat Salvage Option in Implant-Based Breast Reconstruction Failures https://news.medxy.ai/zh/minimally-invasive-breast-augmentation/Medxy AIzh2026-09-30T07:15:40-07:00微创隆胸新进展：恢复更快、感觉更佳，效果优于混合式技术 https://news.medxy.ai/ja/79586-2/Medxy AIja2026-09-30T07:15:24-07:00低侵襲豊胸術の新たな進展：回復が早く、自然な感触を実現し、ハイブリッド法よりも優れた仕上がりに https://news.medxy.ai/vi/minimal-invasive-breast-augmentation/Medxy AIvi2026-09-30T07:15:06-07:00Tăng kích thước vú xâm lấn tối thiểu: Hồi phục nhanh hơn và kết quả cảm giác tốt hơn so với kỹ thuật hybrid https://news.medxy.ai/minimally-invasive-breast-augmentation-enhanced-recovery-and-sensory-outcomes-compared-to-hybrid-techniques/Medxy AIen2026-09-30T07:14:48-07:00Minimally Invasive Breast Augmentation: Enhanced Recovery and Sensory Outcomes Compared to Hybrid Techniques https://news.medxy.ai/zh/79580-2/Medxy AIzh2026-09-30T07:14:17-07:00心脏骤停后神经功能预后评估中的定量瞳孔测量：来自两家医疗机构联合研究的发现 https://news.medxy.ai/ja/pupil-measurement-neuroprognosis/Medxy AIja2026-09-30T07:13:55-07:00心停止後の神経予後予測における定量的瞳孔計測：2施設共同研究からの知見 https://news.medxy.ai/vi/pupil-measurement-neurology/Medxy AIvi2026-09-30T07:13:32-07:00Đo đồng tử định lượng trong tiên lượng thần kinh sau ngừng tim: Nhận định từ một nghiên cứu song trung tâm https://news.medxy.ai/quantitative-pupillometry-in-post-cardiac-arrest-neuroprognostication-insights-from-a-bicentric-study/Medxy AIen2026-09-30T07:13:14-07:00Quantitative Pupillometry in Post-Cardiac Arrest Neuroprognostication: Insights from a Bicentric Study https://news.medxy.ai/zh/icu-pleural-effusion-study/Medxy AIzh2026-09-30T07:12:36-07:00ICU 患者胸腔积液培养阳性的临床意义：一项为期 10 年的人群研究 https://news.medxy.ai/ja/icu-pleural-effusion-study-2/Medxy AIja2026-09-30T07:12:21-07:00ICU患者の胸水培養陽性：10年間の集団ベース研究から見えた臨床的示唆 https://news.medxy.ai/vi/positive-pleural-effusion-icu/Medxy AIvi2026-09-30T07:12:04-07:00Cấy dịch màng phổi dương tính ở bệnh nhân ICU: Những phát hiện từ một nghiên cứu dựa trên quần thể kéo dài 10 năm https://news.medxy.ai/positive-pleural-fluid-cultures-in-icu-patients-insights-from-a-decade-long-population-based-study/Medxy AIen2026-09-30T07:11:44-07:00Positive Pleural Fluid Cultures in ICU Patients: Insights from a Decade-Long Population-Based Study https://news.medxy.ai/zh/suicide-risk-factors-3/Medxy AIzh2026-09-30T07:11:12-07:00急诊青少年后续自杀未遂的关键风险因素：来自PEDSCREEN研究的启示 https://news.medxy.ai/ja/79555-2/Medxy AIja2026-09-30T07:10:57-07:00救急受診した青年におけるその後の自殺未遂の主要なリスク因子 https://news.medxy.ai/vi/79553-2/Medxy AIvi2026-09-30T07:10:39-07:00Các yếu tố nguy cơ chính dẫn đến hành vi tự tử tái diễn ở thanh thiếu niên nhập viện tại Khoa Cấp cứu https://news.medxy.ai/identifying-key-risk-factors-for-subsequent-suicide-attempts-among-youth-in-emergency-departments-insights-from-the-pedscreen-study/Medxy AIen2026-09-30T07:10:22-07:00Identifying Key Risk Factors for Subsequent Suicide Attempts Among Youth in Emergency Departments: Insights from the PEDSCREEN Study https://news.medxy.ai/ja/language-preference-hepatitis-c/Medxy AIja2026-09-30T07:09:45-07:00患者の言語嗜好はC型肝炎スクリーニングにどう影響するのか：DETECT Hep C救急外来スクリーニング試験の結果 https://news.medxy.ai/vi/patient-language-hep-c/Medxy AIvi2026-09-30T07:09:27-07:00Ngôn ngữ ưu tiên của người bệnh có liên quan thế nào đến sàng lọc viêm gan C? Kết quả từ thử nghiệm DETECT Hep C tại khoa cấp cứu https://news.medxy.ai/associations-between-patient-language-preference-and-hepatitis-c-screening-results-from-the-detect-hep-c-emergency-department-screening-trial/Medxy AIen2026-09-30T07:09:05-07:00Associations Between Patient Language Preference and Hepatitis C Screening: Results From the DETECT Hep C Emergency Department Screening Trial https://news.medxy.ai/zh/primary-mediastinal-b-cell-lymphoma/Medxy AIzh2026-09-30T07:08:31-07:00原发性纵隔B细胞淋巴瘤一线治疗的新趋势：来自意大利全国回顾性研究的启示 https://news.medxy.ai/ja/primary-mediastinal-large-b-cell-lymphoma-treatment/Medxy AIja2026-09-30T07:08:14-07:00原発性縦隔大細胞型B細胞リンパ腫の一次治療はどう変わるのか：イタリア全国後ろ向き研究から見えたこと https://news.medxy.ai/vi/primary-mediastinal-b-cell-lymphoma-treatment-trends/Medxy AIvi2026-09-30T07:07:54-07:00Các xu hướng điều trị hàng đầu đang thay đổi trong u lympho tế bào B trung thất nguyên phát: Góc nhìn từ một nghiên cứu hồi cứu trên phạm vi toàn quốc tại Ý https://news.medxy.ai/evolving-first-line-treatments-in-primary-mediastinal-b-cell-lymphoma-insights-from-a-nationwide-italian-retrospective-study/Medxy AIen2026-09-30T07:07:35-07:00Evolving First-Line Treatments in Primary Mediastinal B-Cell Lymphoma: Insights from a Nationwide Italian Retrospective Study https://news.medxy.ai/zh/rituximab-follicular-lymphoma/Medxy AIzh2026-09-30T07:07:00-07:00利妥昔单抗时代转化性滤泡性淋巴瘤：临床结局与预后洞察 https://news.medxy.ai/ja/follicular-lymphoma-transformation/Medxy AIja2026-09-30T07:06:42-07:00リツキシマブ時代の濾胞性リンパ腫形質転換：治療転帰と予後の示唆 https://news.medxy.ai/vi/u-lymphoma-transformation-rituximab/Medxy AIvi2026-09-30T07:06:22-07:00U lympho nang chuyển dạng trong kỷ nguyên rituximab: kết cục điều trị và gợi ý tiên lượng https://news.medxy.ai/transforming-care-in-follicular-lymphoma-outcomes-and-prognostic-insights-in-the-rituximab-era/Medxy AIen2026-09-30T07:06:04-07:00Transforming Care in Follicular Lymphoma: Outcomes and Prognostic Insights in the Rituximab Era https://news.medxy.ai/zh/t-reg-cells-gvhd-prevention/Medxy AIzh2026-09-30T06:23:49-07:00利用抗原特异性供者调节性 T 细胞预防同种异体造血细胞移植中的 GVHD https://news.medxy.ai/ja/donor-regulatory-tcells-gvhd/Medxy AIja2026-09-30T06:23:35-07:00同種造血細胞移植におけるGVHD予防を目指す抗原特異的ドナー制御性T細胞の活用 https://news.medxy.ai/vi/79488-2/Medxy AIvi2026-09-30T06:23:19-07:00Ứng dụng tế bào T điều hòa đặc hiệu kháng nguyên có nguồn gốc từ người hiến nhằm phòng ngừa GVHD trong ghép tế bào tạo máu đồng loài https://news.medxy.ai/harnessing-antigen-specific-donor-regulatory-t-cells-to-prevent-gvhd-in-allogeneic-hematopoietic-cell-transplantation/Medxy AIen2026-09-30T06:23:02-07:00Harnessing Antigen-Specific Donor Regulatory T Cells to Prevent GVHD in Allogeneic Hematopoietic Cell Transplantation https://news.medxy.ai/zh/79485-2/Medxy AIzh2026-09-30T06:22:31-07:00针对骨髓增殖性肿瘤单核细胞过度炎症的Galectin-1靶向治疗潜力 https://news.medxy.ai/ja/galectin-1-targeting/Medxy AIja2026-09-30T06:22:14-07:00骨髄増殖性腫瘍の単球性過炎症に対するGalectin-1標的化の可能性 https://news.medxy.ai/vi/target-galectin-1-inflammation/Medxy AIvi2026-09-30T06:21:55-07:00Nhắm đích Galectin-1 để giảm tình trạng tăng viêm do bạch cầu đơn nhân trong tân sinh tăng sinh tủy xương https://news.medxy.ai/targeting-galectin-1-to-mitigate-monocyte-driven-hyperinflammation-in-myeloproliferative-neoplasms/Medxy AIen2026-09-30T06:21:37-07:00Targeting Galectin-1 to Mitigate Monocyte-Driven Hyperinflammation in Myeloproliferative Neoplasms https://news.medxy.ai/zh/multi-component-lung-rehab/Medxy AIzh2026-09-30T06:21:01-07:00多组分肺康复可显著改善长期机械通气高龄患者的撤机结局 https://news.medxy.ai/ja/multi-factor-lung-rehabilitation/Medxy AIja2026-09-30T06:20:45-07:00多要素肺リハビリテーションが長期人工呼吸管理中の高齢患者における離脱成績を大きく改善 https://news.medxy.ai/vi/multi-component-lung-rehab-2/Medxy AIvi2026-09-30T06:20:29-07:00Phục hồi chức năng phổi đa thành phần giúp cải thiện rõ rệt kết quả cai máy thở ở bệnh nhân cao tuổi thở máy kéo dài https://news.medxy.ai/multicomponent-pulmonary-rehabilitation-significantly-enhances-weaning-outcomes-in-elderly-patients-on-prolonged-mechanical-ventilation/Medxy AIen2026-09-30T06:20:13-07:00Multicomponent Pulmonary Rehabilitation Significantly Enhances Weaning Outcomes in Elderly Patients on Prolonged Mechanical Ventilation https://news.medxy.ai/zh/ct-mucus-plug-copd/Medxy AIzh2026-09-30T06:19:39-07:00胸部CT气道黏液栓：预测COPD及肺功能保留者呼吸结局的关键线索——来自中国队列的发现 https://news.medxy.ai/ja/79474-2/Medxy AIja2026-09-30T06:19:26-07:00胸部CTにおける気道粘液栓：COPDおよび肺機能が保たれた症例の呼吸器予後を予測する重要な手がかり https://news.medxy.ai/vi/airway-mucus-ct/Medxy AIvi2026-09-30T06:19:09-07:00Nút nhầy đường thở trên CT: Dự báo kết cục hô hấp trong COPD và hô hấp ký còn bảo tồn — Dữ liệu từ một đoàn hệ Trung Quốc https://news.medxy.ai/airway-mucus-plugs/Medxy AIen2026-09-30T06:18:53-07:00Airway Mucus Plugs on CT: Predicting Respiratory Outcomes in COPD and Preserved Spirometry — Insights from a Chinese Cohort https://news.medxy.ai/zh/79470-2/Medxy AIzh2026-09-30T06:18:21-07:00通过聚类分析阐明慢性中心性浆液性脉络膜视网膜病变的结构表型：基于临床表现与影像学发现 https://news.medxy.ai/ja/chronic-csr/Medxy AIja2026-09-30T06:18:02-07:00慢性中心性漿液性脈絡網膜症の構造的表現型をクラスタリングで解明：臨床像と画像所見から見る新知見 https://news.medxy.ai/vi/three-structural-patterns-central-serous-chorioretinopathy/Medxy AIvi2026-09-30T06:17:41-07:00Ba kiểu hình cấu trúc của viêm võng mạc hắc mạc thanh dịch trung tâm mạn tính: góc nhìn lâm sàng và hình ảnh học https://news.medxy.ai/cluster-based-structural-phenotypes-of-chronic-central-serous-chorioretinopathy-clinical-and-imaging-insights/Medxy AIen2026-09-30T06:17:17-07:00Cluster-Based Structural Phenotypes of Chronic Central Serous Chorioretinopathy: Clinical and Imaging Insights https://news.medxy.ai/zh/structured-coaching-benefits/Medxy AIzh2026-09-30T06:16:28-07:00结构化辅导提升医师福祉：学术型耳鼻喉科学试点研究的启示 https://news.medxy.ai/ja/structured-coaching-wellbeing/Medxy AIja2026-09-30T06:16:13-07:00構造化コーチングで医師のウェルビーイングを高める：学術耳鼻咽喉科におけるパイロット研究からの示唆 https://news.medxy.ai/vi/structured-training-mental-health/Medxy AIvi2026-09-30T06:15:57-07:00Huấn luyện có cấu trúc: hướng đi mới giúp nâng cao sức khỏe tinh thần cho bác sĩ Tai Mũi Họng trong môi trường học thuật https://news.medxy.ai/enhancing-physician-well-being-through-structured-coaching-insights-from-a-pilot-study-in-academic-otolaryngology/Medxy AIen2026-09-30T06:15:43-07:00Enhancing Physician Well-Being Through Structured Coaching: Insights from a Pilot Study in Academic Otolaryngology https://news.medxy.ai/zh/chronic-steroid-use-risk/Medxy AIzh2026-09-30T06:15:13-07:00慢性激素使用并不会增加远端胰腺切除术后的短期风险：来自大型国家数据库的研究提示 https://news.medxy.ai/ja/distal-pancreatectomy-risks/Medxy AIja2026-09-30T06:14:57-07:00遠位膵切除後の短期リスクは慢性ステロイド使用で上がらない―大規模全国データベースが示す新知見 https://news.medxy.ai/vi/chronic-steroid-use-risk-2/Medxy AIvi2026-09-30T06:14:39-07:00Dùng steroid mạn tính không làm tăng nguy cơ ngắn hạn sau cắt tụy đoạn xa: Góc nhìn từ một cơ sở dữ liệu quốc gia quy mô lớn https://news.medxy.ai/chronic-steroid-use-does-not-increase-short-term-risks-after-distal-pancreatectomy-insights-from-a-large-national-database/Medxy AIen2026-09-30T06:14:23-07:00Chronic Steroid Use Does Not Increase Short-Term Risks After Distal Pancreatectomy: Insights from a Large National Database https://news.medxy.ai/zh/asd-child-gastrostomy-outcomes/Medxy AIzh2026-09-30T06:13:53-07:00ASD儿童行胃造口管置入后的术后结局：发育迟缓与营养支持才是关键 https://news.medxy.ai/ja/gastrostomy-tube-outcomes/Medxy AIja2026-09-30T06:13:37-07:00胃瘻チューブ留置を受ける自閉スペクトラム症小児の術後転帰を評価する https://news.medxy.ai/vi/surgery-outcomes-autism/Medxy AIvi2026-09-30T06:13:21-07:00Đánh giá kết cục sau phẫu thuật ở trẻ mắc rối loạn phổ tự kỷ sau đặt ống mở thông dạ dày https://news.medxy.ai/evaluating-postoperative-outcomes-in-children-with-autism-spectrum-disorder-undergoing-gastrostomy-tube-placement/Medxy AIen2026-09-30T06:13:06-07:00Evaluating Postoperative Outcomes in Children with Autism Spectrum Disorder Undergoing Gastrostomy Tube Placement https://news.medxy.ai/ja/post-esophagectomy-symptom-management/Medxy AIja2026-09-30T06:12:32-07:00食道胃切除後の症状管理を標準化するEUROSTAR/POQIコンセンサス https://news.medxy.ai/vi/79449-2/Medxy AIvi2026-09-30T06:12:03-07:00Đồng thuận EUROSTAR/POQI: Chuẩn hóa quy trình quản lý triệu chứng sau phẫu thuật cắt thực quản – dạ dày https://news.medxy.ai/zh/eurostar-poqi-consensus/Medxy AIzh2026-09-30T06:11:32-07:00EUROSTAR/POQI 共识：规范食管胃切除术后症状管理 https://news.medxy.ai/standardising-post-surgery-care/Medxy AIen2026-09-30T06:11:04-07:00EUROSTAR/POQI Consensus: Standardising Care for Symptoms After Oesophago‑Gastric Resection https://news.medxy.ai/zh/patient-doctor-perspective/Medxy AIzh2026-09-30T06:10:01-07:00连接患者与医生视角：赞比亚慢性神经系统疾病中患者报告与临床医生评估改良Rankin量表评分的比较 https://news.medxy.ai/ja/zambia-neuro-score/Medxy AIja2026-09-30T06:09:44-07:00橋渡しする視点：ザンビアの慢性神経疾患における患者報告と医師評価による修正ランキン尺度スコアの比較 https://news.medxy.ai/vi/rankin-scale-comparison/Medxy AIvi2026-09-30T06:09:27-07:00Kết nối hai góc nhìn: so sánh điểm modified Rankin Scale do người bệnh tự báo cáo và do bác sĩ đánh giá ở các rối loạn thần kinh mạn tính tại Zambia https://news.medxy.ai/bridging-perspectives-comparing-patient-reported-and-physician-assessed-modified-rankin-scale-scores-in-chronic-neurologic-disorders-in-zambia/Medxy AIen2026-09-30T06:09:09-07:00Bridging Perspectives: Comparing Patient-Reported and Physician-Assessed Modified Rankin Scale Scores in Chronic Neurologic Disorders in Zambia https://news.medxy.ai/zh/physical-activity-diabetes-risk/Medxy AIzh2026-09-30T06:08:34-07:00偶发性体力活动强度与2型糖尿病风险：一项大型可穿戴设备队列研究的新发现 https://news.medxy.ai/ja/diabetes-risk-exercise/Medxy AIja2026-09-30T06:08:16-07:00日常の“ついで運動”が2型糖尿病リスクを下げる：大規模ウェアラブル研究が示す強度別の効果 https://news.medxy.ai/vi/random-physical-activity-diabetes-risk/Medxy AIvi2026-09-30T06:07:53-07:00Hoạt động thể chất ngẫu nhiên và nguy cơ đái tháo đường týp 2: phát hiện từ một nghiên cứu đoàn hệ lớn dựa trên thiết bị đeo https://news.medxy.ai/incidental-physical-activity-intensity-and-type-2-diabetes-risk-insights-from-a-large-wearable-based-cohort-study/Medxy AIen2026-09-30T06:07:34-07:00Incidental Physical Activity Intensity and Type 2 Diabetes Risk: Insights from a Large Wearable-Based Cohort Study https://news.medxy.ai/zh/nsd2-targeted-therapy-2/Medxy AIzh2026-09-30T02:49:54-07:00靶向 NSD2 降解：高风险 t(4;14) 多发性骨髓瘤的新型治疗路径 https://news.medxy.ai/ja/nsd2-targeted-therapy/Medxy AIja2026-09-30T02:49:35-07:00高リスクt(4;14)多発性骨髄腫に対する新規治療戦略：NSD2分解標的化 https://news.medxy.ai/vi/nsd2-degradation-treatment/Medxy AIvi2026-09-30T02:49:11-07:00Nhắm vào thoái hóa NSD2: hướng điều trị mới cho đa u tủy xương nguy cơ cao mang chuyển đoạn t(4;14) https://news.medxy.ai/targeting-nsd2-degradation-a-novel-therapeutic-avenue-for-high-risk-t414-multiple-myeloma/Medxy AIen2026-09-30T02:48:49-07:00Targeting NSD2 Degradation: A Novel Therapeutic Avenue for High-Risk t(4;14) Multiple Myeloma https://news.medxy.ai/zh/in-hospital-vfib-treatment/Medxy AIzh2026-09-30T02:48:05-07:00院内难治性室颤：利多卡因与胺碘酮谁更优？中国全国注册研究给出答案 https://news.medxy.ai/ja/lidocaine-amiodarone-ventricular-fibrillation/Medxy AIja2026-09-30T02:47:44-07:00難治性心室細動に対するリドカインとアミオダロン：成人院内心停止における全国中国レジストリ研究 https://news.medxy.ai/vi/lidocaine-vs-amiodarone/Medxy AIvi2026-09-30T02:47:24-07:00Lidocaine hay amiodarone: thuốc nào tốt hơn cho rung thất kháng trị trong ngừng tim nội viện ở người lớn? Bằng chứng từ cơ sở dữ liệu toàn quốc của Trung Quốc https://news.medxy.ai/lidocaine-versus-amiodarone-for-refractory-ventricular-fibrillation-in-adult-in-hospital-cardiac-arrest-evidence-from-a-nationwide-chinese-registry/Medxy AIen2026-09-30T02:47:02-07:00Lidocaine Versus Amiodarone for Refractory Ventricular Fibrillation in Adult In-Hospital Cardiac Arrest: Evidence from a Nationwide Chinese Registry https://news.medxy.ai/zh/79118-2/Medxy AIzh2026-09-30T02:46:24-07:00全球角膜移植与眼库调查十年进展：应对供需失衡与临床实践的转变 https://news.medxy.ai/ja/79117-2/Medxy AIja2026-09-30T02:46:05-07:00角膜移植とアイバンクに関する世界調査の10年間のアップデート：需給の不均衡と診療実態の変化への対応 https://news.medxy.ai/vi/cornea-transplant-survey/Medxy AIvi2026-09-30T02:45:39-07:00Cập nhật 10 năm về khảo sát toàn cầu ghép giác mạc và ngân hàng mắt: Giải quyết chênh lệch cung–cầu và sự thay đổi thực hành https://news.medxy.ai/ten-year-update-of-a-global-survey-of-corneal-transplant-and-eye-banking-addressing-supply-demand-disparities-and-evolving-practices/Medxy AIen2026-09-30T02:45:15-07:00Ten-Year Update of a Global Survey of Corneal Transplant and Eye Banking: Addressing Supply-Demand Disparities and Evolving Practices https://news.medxy.ai/zh/pediatric-tracheostomy-risk-2/Medxy AIzh2026-09-29T10:44:14-07:00儿童气管切开术住院风险分层新进展：基于特异性分层体系的评估 https://news.medxy.ai/ja/pediatric-tracheostomy-risk/Medxy AIja2026-09-29T10:43:56-07:00小児気管切開入院のリスク層別化を刷新する新手法：気管切開特異的リスク層システムの検証 https://news.medxy.ai/vi/tracheostomy-risk-stratification/Medxy AIvi2026-09-29T10:43:37-07:00Cải thiện phân tầng nguy cơ cho các ca nhập viện mở khí quản ở trẻ em: Đánh giá một hệ thống phân tầng mới đặc hiệu cho mở khí quản https://news.medxy.ai/enhanced-risk-stratification-for-pediatric-tracheostomy-hospitalizations-evaluating-a-novel-tracheostomy-specific-tier-system/Medxy AIen2026-09-29T10:43:20-07:00Enhanced Risk Stratification for Pediatric Tracheostomy Hospitalizations: Evaluating a Novel Tracheostomy-Specific Tier System https://news.medxy.ai/zh/pediatric-laryngotracheal-repair/Medxy AIzh2026-09-29T10:42:35-07:00儿童I型喉裂修补后吞咽功能的长期转归 https://news.medxy.ai/ja/type-1-laryngeal-cleft/Medxy AIja2026-09-29T10:42:18-07:00Ⅰ型喉頭裂修復後の小児における嚥下障害の長期転帰 https://news.medxy.ai/vi/long-term-dysphagia-outcome/Medxy AIvi2026-09-29T10:41:55-07:00Kết cục dài hạn của rối loạn nuốt sau sửa chữa khe hở thanh quản loại I ở trẻ em https://news.medxy.ai/long-term-outcomes-of-dysphagia-following-type-i-laryngeal-cleft-repair-in-children/Medxy AIen2026-09-29T10:41:38-07:00Long-Term Outcomes of Dysphagia Following Type I Laryngeal Cleft Repair in Children https://news.medxy.ai/zh/thyroid-surgery-parathyroid-injury/Medxy AIzh2026-09-29T10:41:04-07:00甲状腺手术中误切甲状旁腺：发生率、危险因素与临床影响 https://news.medxy.ai/ja/accidental-parathyroidectomy/Medxy AIja2026-09-29T10:40:47-07:00甲状腺手術中の偶発的副甲状腺切除：発生率・リスク因子・臨床的意義 https://news.medxy.ai/vi/79083-2/Medxy AIvi2026-09-29T10:40:27-07:00Cắt bỏ tuyến cận giáp ngoài ý muốn trong phẫu thuật tuyến giáp: Tỷ lệ mắc, yếu tố nguy cơ và ý nghĩa lâm sàng https://news.medxy.ai/inadvertent-parathyroidectomy-during-thyroid-surgery-incidence-risk-factors-and-clinical-implications/Medxy AIen2026-09-29T10:40:07-07:00Inadvertent Parathyroidectomy During Thyroid Surgery: Incidence, Risk Factors, and Clinical Implications https://news.medxy.ai/zh/surgery-teacher-retention/Medxy AIzh2026-09-29T10:39:26-07:00外科教师为何留任或离职：影响去留决策的关键因素 https://news.medxy.ai/ja/79073-2/Medxy AIja2026-09-29T10:39:09-07:00外科系教員の引き留め：残留か離職かを左右する重要な要因 https://news.medxy.ai/vi/retain-surgery-instructors/Medxy AIvi2026-09-29T10:38:50-07:00Giữ chân giảng viên phẫu thuật: Những yếu tố then chốt quyết định ở lại hay rời đi https://news.medxy.ai/understanding-surgical-faculty-retention-key-factors-influencing-their-decision-to-stay-or-leave/Medxy AIen2026-09-29T10:38:33-07:00Understanding Surgical Faculty Retention: Key Factors Influencing Their Decision to Stay or Leave https://news.medxy.ai/zh/79065-2/Medxy AIzh2026-09-29T10:37:53-07:00多发性硬化症中多领域生活方式干预的持续效应——基于LIMS研究24个月随访的启示 https://news.medxy.ai/ja/multiple-sclerosis-lifestyle/Medxy AIja2026-09-29T10:37:35-07:00多発性硬化症における多領域ライフスタイル介入の持続効果――LIMS研究24か月追跡から見えた示唆 https://news.medxy.ai/vi/sustainable-lifestyle-benefits/Medxy AIvi2026-09-29T10:37:12-07:00Lợi ích bền vững của can thiệp lối sống đa mô thức ở bệnh đa xơ cứng: Những phát hiện từ theo dõi 24 tháng của nghiên cứu LIMS https://news.medxy.ai/sustained-benefits-of-a-multidomain-lifestyle-intervention-in-multiple-sclerosis-insights-from-the-24-month-lims-study-follow-up/Medxy AIen2026-09-29T10:36:51-07:00Sustained Benefits of a Multidomain Lifestyle Intervention in Multiple Sclerosis: Insights from the 24-Month LIMS Study Follow-Up https://news.medxy.ai/zh/gastric-emptying-glp1/Medxy AIzh2026-09-29T10:36:02-07:00术后减重手术低血糖中的胃排空加速：GLP-1受体激动剂的作用再评估 https://news.medxy.ai/ja/postoperative-hypoglycemia/Medxy AIja2026-09-29T10:35:47-07:00術後低血糖における胃排出亢進：GLP-1受容体作動薬の位置づけを検討する https://news.medxy.ai/vi/empty-stomach-after-bariatric-surgery/Medxy AIvi2026-09-29T10:35:25-07:00Làm rỗng dạ dày nhanh trong hạ đường huyết sau phẫu thuật béo phì: Đánh giá vai trò của chất chủ vận thụ thể GLP-1 https://news.medxy.ai/rapid-gastric-emptying-in-postbariatric-hypoglycemia-evaluating-the-role-of-glp-1-receptor-agonists/Medxy AIen2026-09-29T10:35:07-07:00Rapid Gastric Emptying in Postbariatric Hypoglycemia: Evaluating the Role of GLP-1 Receptor Agonists https://news.medxy.ai/zh/semaglutide-weight-loss-4/Medxy AIzh2026-09-29T10:34:16-07:00司美格鲁肽在心血管患者中的最大减重预测因素：SELECT试验带来的启示 https://news.medxy.ai/ja/semaglutide-weight-loss-3/Medxy AIja2026-09-29T10:33:58-07:00SELECT試験が示した、心血管疾患患者におけるセマグルチド減量効果の予測因子とは https://news.medxy.ai/vi/weight-loss-predictors-semaglutide/Medxy AIvi2026-09-29T10:33:40-07:00Những yếu tố nào dự báo mức giảm cân tối đa với semaglutide ở bệnh nhân tim mạch? Góc nhìn từ thử nghiệm SELECT https://news.medxy.ai/unraveling-the-predictors-of-peak-weight-loss-with-semaglutide-in-cardiovascular-patients-insights-from-the-select-trial/Medxy AIen2026-09-29T10:33:23-07:00Unraveling the Predictors of Peak Weight Loss with Semaglutide in Cardiovascular Patients: Insights from the SELECT Trial https://news.medxy.ai/zh/hodgkin-lymphoma-immunotherapy/Medxy AIzh2026-09-29T10:30:01-07:00经典霍奇金淋巴瘤中免疫检查点抑制剂再挑战：来自院外队列的疗效与安全性启示 https://news.medxy.ai/ja/hodgkin-lymphoma-immunotherapy-2/Medxy AIja2026-09-29T10:29:44-07:00古典的ホジキンリンパ腫における免疫チェックポイント阻害薬再投与：治験外コホートからみた有効性と安全性 https://news.medxy.ai/vi/immune-checkpoint-inhibitors-2/Medxy AIvi2026-09-29T10:29:24-07:00Tái dùng thuốc ức chế điểm kiểm soát miễn dịch trong u lympho Hodgkin kinh điển: Những góc nhìn về hiệu quả và độ an toàn từ một đoàn hệ ngoài thử nghiệm https://news.medxy.ai/immune-checkpoint-inhibitor-rechallenge-in-classical-hodgkin-lymphoma-efficacy-and-safety-insights-from-an-off-trial-cohort/Medxy AIen2026-09-29T10:29:07-07:00Immune Checkpoint Inhibitor Rechallenge in Classical Hodgkin Lymphoma: Efficacy and Safety Insights from an Off-Trial Cohort https://news.medxy.ai/zh/79034-2/Medxy AIzh2026-09-29T10:28:28-07:00靶向 TYK2：CALR 突变型骨髓增殖性肿瘤的一个新型治疗靶点 https://news.medxy.ai/ja/calr-mutant-mpns-therapy/Medxy AIja2026-09-29T10:28:08-07:00CALR変異陽性MPNsにおける新たな治療脆弱性：TYK2を標的とする戦略 https://news.medxy.ai/vi/tyk2-target-mutation/Medxy AIvi2026-09-29T10:27:41-07:00Nhắm trúng TYK2: điểm yếu điều trị mới trong u tân sinh tăng sinh tủy mang đột biến CALR https://news.medxy.ai/targeting-tyk2-a-novel-therapeutic-vulnerability-in-calr-mutant-myeloproliferative-neoplasms/Medxy AIen2026-09-29T10:27:19-07:00Targeting TYK2: A Novel Therapeutic Vulnerability in CALR-Mutant Myeloproliferative Neoplasms https://news.medxy.ai/zh/fibroblasts-pitavastatin-treatment/Medxy AIzh2026-09-29T10:26:34-07:00纤维细胞与 pitavastatin 在 JAK2V617F 突变型骨髓纤维化中的治疗潜力：一项综合综述 https://news.medxy.ai/ja/jak2v617f-myelofibrosis-treatment/Medxy AIja2026-09-29T10:26:15-07:00JAK2V617F変異骨髄線維症における線維細胞とpitavastatinの治療可能性：包括的レビュー https://news.medxy.ai/vi/fibrocytes-pitavastatin-myelofibrosis/Medxy AIvi2026-09-29T10:25:53-07:00Fibrocytes và tiềm năng điều trị của pitavastatin trong myelofibrosis đột biến JAK2V617F: Tổng quan toàn diện https://news.medxy.ai/fibrocytes-and-therapeutic-potential-of-pitavastatin-in-jak2v617f-mutated-myelofibrosis-a-comprehensive-review/Medxy AIen2026-09-29T10:25:31-07:00Fibrocytes and Therapeutic Potential of Pitavastatin in JAK2V617F-Mutated Myelofibrosis: A Comprehensive Review https://news.medxy.ai/zh/pulmonary-artery-dilation/Medxy AIzh2026-09-29T10:24:34-07:00慢性肺疾病中肺动脉扩张：肺动脉高压的影像学信号——来自PVDOMICS队列的研究 https://news.medxy.ai/ja/pulmonary-hypertension-markers/Medxy AIja2026-09-29T10:24:17-07:00慢性肺疾患における肺高血圧の指標としての肺動脈拡張：PVDOMICSコホートからの知見 https://news.medxy.ai/vi/pulmonary-artery-dilation-2/Medxy AIvi2026-09-29T10:23:58-07:00Giãn động mạch phổi trên CT ngực: Dấu ấn gợi ý tăng áp phổi trong bệnh phổi mạn tính từ đoàn hệ PVDOMICS https://news.medxy.ai/pulmonary-artery-dilation-as-a-mark-of-pulmonary-hypertension-in-chronic-lung-disease-insights-from-the-pvdomics-cohort/Medxy AIen2026-09-29T10:23:41-07:00Pulmonary Artery Dilation as a Mark of Pulmonary Hypertension in Chronic Lung Disease: Insights from the PVDOMICS Cohort https://news.medxy.ai/zh/copd-progression-prediction/Medxy AIzh2026-09-29T10:22:51-07:00通过1年CT肺气肿亚型进展预测COPD肺功能下降：SPIROMICS研究新启示 https://news.medxy.ai/ja/copd-progress-prediction/Medxy AIja2026-09-29T10:22:34-07:001年間のCT肺気腫サブタイプ進展からみるCOPDの肺機能低下予測：SPIROMICS研究の示唆 https://news.medxy.ai/vi/copd-lung-function-decline/Medxy AIvi2026-09-29T10:22:13-07:00Dự báo suy giảm chức năng phổi ở COPD qua tiến triển 1 năm của phân nhóm khí phế thũng trên CT: Những phát hiện từ SPIROMICS https://news.medxy.ai/predicting-lung-function-decline-in-copd-via-one-year-ct-emphysema-subtype-progression-insights-from-spiromics/Medxy AIen2026-09-29T10:21:52-07:00Predicting Lung Function Decline in COPD via One-Year CT Emphysema Subtype Progression: Insights from SPIROMICS https://news.medxy.ai/zh/eyelid-drooping-assessment/Medxy AIzh2026-09-29T10:21:07-07:00眼睑下垂评估迈入新阶段：基于智能手机的3D眼部重建提升精确度与临床决策能力 https://news.medxy.ai/ja/eyelid-ptosis-evaluation/Medxy AIja2026-09-29T10:20:48-07:00眼瞼下垂評価を次の段階へ：スマートフォン3D眼再構成が精度と臨床判断を高める https://news.medxy.ai/vi/eyelid-droop-3d-reconstruction/Medxy AIvi2026-09-29T10:20:28-07:00Đánh Giá Sụp Mi Tiến Bộ Hơn: Tái Tạo Nhãn Cầu 3D Bằng Điện Thoại Thông Minh Nâng Cao Độ Chính Xác và Quyết Định Lâm Sàng https://news.medxy.ai/advancing-blepharoptosis-assessment-smartphone-based-3d-ocular-reconstruction-enhances-precision-and-clinical-decision-making/Medxy AIen2026-09-29T10:20:09-07:00Advancing Blepharoptosis Assessment: Smartphone-Based 3D Ocular Reconstruction Enhances Precision and Clinical Decision-Making https://news.medxy.ai/zh/cambridge-freezing-therapy-2/Medxy AIzh2026-09-29T10:19:27-07:00Cambridge预防性冷冻治疗：降低2型Stickler综合征视网膜脱离风险的有效策略 https://news.medxy.ai/ja/cambridge-freezing-therapy/Medxy AIja2026-09-29T10:19:11-07:00Cambridge予防的凍結療法で2型スティックラー症候群の網膜剥離を強力に予防 https://news.medxy.ai/vi/cold-therapy-stickler-type-2/Medxy AIvi2026-09-29T10:18:52-07:00Liệu pháp lạnh dự phòng Cambridge: giải pháp hiệu quả ngăn bong võng mạc ở hội chứng Stickler type 2 https://news.medxy.ai/effective-retinal-detachment-prevention-in-type-2-stickler-syndrome-using-cambridge-prophylactic-cryotherapy/Medxy AIen2026-09-29T10:18:33-07:00Effective Retinal Detachment Prevention in Type 2 Stickler Syndrome Using Cambridge Prophylactic Cryotherapy https://news.medxy.ai/zh/low-awakening-threshold-predicts-compliance/Medxy AIzh2026-09-29T10:17:55-07:00低觉醒阈值可预测阻塞性睡眠呼吸暂停患者对舌下神经刺激的长期依从性 https://news.medxy.ai/ja/low-arousal-threshold/Medxy AIja2026-09-29T10:17:38-07:00低覚醒閾値は舌下神経刺激療法の長期継続を予測できるか https://news.medxy.ai/vi/low-arousal-threshold-2/Medxy AIvi2026-09-29T10:17:16-07:00Ngưỡng thức giấc thấp: Dấu hiệu dự báo tuân thủ lâu dài với kích thích thần kinh hạ thiệt trong ngưng thở tắc nghẽn khi ngủ https://news.medxy.ai/low-arousal-threshold-as-a-predictor-of-long-term-adherence-to-hypoglossal-nerve-stimulation-in-obstructive-sleep-apnea/Medxy AIen2026-09-29T10:16:57-07:00Low Arousal Threshold as a Predictor of Long-Term Adherence to Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea https://news.medxy.ai/zh/hearing-loss-outcomes/Medxy AIzh2026-09-29T10:16:12-07:00耳聋越久，效果越差吗？——人工耳蜗植入后言语结局的十年临床数据揭秘 https://news.medxy.ai/ja/hearing-implant-benefits/Medxy AIja2026-09-29T10:15:56-07:00難聴期間が長くても人工内耳で改善は得られるのか：10年にわたる臨床データからの知見 https://news.medxy.ai/vi/hearing-loss-outcomes-2/Medxy AIvi2026-09-29T10:15:37-07:00Điếc kéo dài và kết quả lời nói sau cấy ốc tai điện tử: Góc nhìn từ dữ liệu lâm sàng 10 năm https://news.medxy.ai/prolonged-deafness-duration-and-speech-outcomes-after-cochlear-implantation-insights-from-a-decade-of-clinical-data/Medxy AIen2026-09-29T10:15:17-07:00Prolonged Deafness Duration and Speech Outcomes After Cochlear Implantation: Insights from a Decade of Clinical Data https://news.medxy.ai/zh/necrotizing-pancreatitis-colon-fistula/Medxy AIzh2026-09-29T10:14:40-07:00坏死性胰腺炎相关结肠瘘的非手术处理：识别适合保守治疗的患者 https://news.medxy.ai/ja/necrotizing-pancreatitis-colon-fistula-2/Medxy AIja2026-09-29T10:14:21-07:00壊死性膵炎に伴う結腸瘻の非手術的管理：保存的治療の適応を見極める https://news.medxy.ai/vi/78954-2/Medxy AIvi2026-09-29T10:13:59-07:00Quản lý không phẫu thuật đối với rò đại tràng liên quan đến viêm tụy hoại tử: xác định các bệnh nhân phù hợp với điều trị bảo tồn https://news.medxy.ai/nonoperative-management-of-colonic-fistulas-in-necrotizing-pancreatitis-identifying-candidates-for-conservative-care/Medxy AIen2026-09-29T10:13:41-07:00Nonoperative Management of Colonic Fistulas in Necrotizing Pancreatitis: Identifying Candidates for Conservative Care https://news.medxy.ai/ja/colon-rectal-trauma-treatment/Medxy AIja2026-09-29T10:12:58-07:00結腸・直腸外傷の治療は生理学で選ぶ時代へ：2026年WSESコンセンサスの重要推奨 https://news.medxy.ai/vi/selective-care-colorectal-trauma/Medxy AIvi2026-09-29T10:12:23-07:00Chăm sóc chọn lọc, dựa trên sinh lý trong chấn thương đại trực tràng: các khuyến cáo then chốt từ đồng thuận WSES 2026 https://news.medxy.ai/zh/colon-rectal-trauma/Medxy AIzh2026-09-29T10:11:50-07:00结肠与直肠创伤的选择性、生理驱动型处理：2026年WSES共识关键建议 https://news.medxy.ai/selective-physiology-driven-care-for-colon-and-rectal-trauma-key-recommendations-from-the-2026-wses-consensus/Medxy AIen2026-09-29T10:11:21-07:00Selective, Physiology-Driven Care for Colon and Rectal Trauma: Key Recommendations from the 2026 WSES Consensus https://news.medxy.ai/zh/her2-scoring-discrepancy/Medxy AIzh2026-09-29T10:10:18-07:00子宫内膜取样与子宫切除标本的胃癌HER2评分为何不一致：高分级子宫内膜癌的临床启示 https://news.medxy.ai/ja/78934-2/Medxy AIja2026-09-29T10:10:00-07:00子宮内膜生検検体と子宮摘出検体におけるHER2スコアの不一致：高悪性度子宮内膜癌における臨床的意義 https://news.medxy.ai/vi/her2-gastric-endometrial-cancer/Medxy AIvi2026-09-29T10:09:40-07:00Điểm HER2 theo tiêu chuẩn dạ dày ở sinh thiết nội mạc tử cung và bệnh phẩm cắt tử cung: Hệ quả lâm sàng trong ung thư nội mạc tử cung độ cao https://news.medxy.ai/discordance-between-gastric-her2-scoring-in-endometrial-sampling-versus-hysterectomy-specimens-clinical-implications-in-high-grade-endometrial-cancer/Medxy AIen2026-09-29T10:09:22-07:00Discordance Between Gastric HER2 Scoring in Endometrial Sampling Versus Hysterectomy Specimens: Clinical Implications in High-Grade Endometrial Cancer https://news.medxy.ai/zh/peritoneal-fluid-exosomes/Medxy AIzh2026-09-29T10:08:42-07:00腹膜液小细胞外囊泡蛋白：开启子宫内膜异位症诊断新潜力 https://news.medxy.ai/ja/endometriosis-diagnostics/Medxy AIja2026-09-29T10:08:23-07:00子宮内膜症における腹膜液由来小型細胞外小胞タンパク質の診断的可能性を探る https://news.medxy.ai/vi/protein-diagnostics-endometriosis/Medxy AIvi2026-09-29T10:08:02-07:00Tiềm năng chẩn đoán của protein trong túi ngoại bào kích thước nhỏ từ dịch phúc mạc ở lạc nội mạc tử cung https://news.medxy.ai/unlocking-the-diagnostic-potential-of-peritoneal-fluid-small-extracellular-vesicle-proteins-in-endometriosis/Medxy AIen2026-09-29T10:07:41-07:00Unlocking the Diagnostic Potential of Peritoneal Fluid Small Extracellular Vesicle Proteins in Endometriosis https://news.medxy.ai/ja/78912-2/Medxy AIja2026-09-29T10:07:03-07:00肝細胞癌に対する全身療法と手術・局所領域療法の併用：HCC-Live専門家コンセンサスによる臨床試験デザインへの重要な提言 https://news.medxy.ai/vi/hcc-live-guidelines/Medxy AIvi2026-09-29T10:06:27-07:00Thiết kế thử nghiệm chặt chẽ cho liệu pháp toàn thân kết hợp phẫu thuật và điều trị tại chỗ-vùng trong ung thư biểu mô tế bào gan: khuyến nghị then chốt từ đồng thuận chuyên gia HCC-Live https://news.medxy.ai/zh/hcc-treatment-guidelines/Medxy AIzh2026-09-29T10:05:55-07:00肝细胞癌系统治疗联合手术与局部区域治疗：HCC-Live专家共识对临床试验设计的关键建议 https://news.medxy.ai/designing-rigorous-trials-of-systemic-therapy-with-surgery-and-locoregional-treatment-in-hepatocellular-carcinoma-key-recommendations-from-an-hcc-live-expert-consensus/Medxy AIen2026-09-29T10:05:25-07:00Designing Rigorous Trials of Systemic Therapy with Surgery and Locoregional Treatment in Hepatocellular Carcinoma: Key Recommendations from an HCC-Live Expert Consensus https://news.medxy.ai/zh/ms-treatment-progress/Medxy AIzh2026-09-29T10:04:16-07:00进展型多发性硬化治疗评估新进展：MAMS临床试验中的患者报告中期结局 https://news.medxy.ai/ja/progressive-ms-treatment/Medxy AIja2026-09-29T10:03:56-07:00進行型多発性硬化症における治療評価の前進：MAMS臨床試験における患者報告アウトカムの中間評価 https://news.medxy.ai/vi/78898-2/Medxy AIvi2026-09-29T10:03:35-07:00Những tiến bộ mới trong đánh giá hiệu quả điều trị bệnh đa xơ cứng tiến triển: Các kết quả trung gian do bệnh nhân tự báo cáo trong các thử nghiệm lâm sàng MAMS https://news.medxy.ai/advancing-treatment-evaluation-in-progressive-multiple-sclerosis-interim-patient-reported-outcomes-for-mams-clinical-trials/Medxy AIen2026-09-29T10:03:15-07:00Advancing Treatment Evaluation in Progressive Multiple Sclerosis: Interim Patient-Reported Outcomes for MAMS Clinical Trials https://news.medxy.ai/zh/lecanemab-alzheimers-biomarkers/Medxy AIzh2026-09-29T10:02:35-07:00动态血浆生物标志物揭示 lecanemab 在早期阿尔茨海默病中的多重作用 https://news.medxy.ai/ja/78894-2/Medxy AIja2026-09-29T10:02:18-07:00動的な血漿バイオマーカーが明らかにする、早期アルツハイマー病におけるレカネマブの多面的な作用 https://news.medxy.ai/vi/lecanemab-alzheimer-impact/Medxy AIvi2026-09-29T10:01:56-07:00Dấu ấn sinh học huyết tương động cho thấy tác động đa chiều của lecanemab ở bệnh Alzheimer giai đoạn sớm https://news.medxy.ai/dynamic-plasma-biomarkers-reveal-multifaceted-effects-of-lecanemab-in-early-alzheimers-disease/Medxy AIen2026-09-29T10:01:33-07:00Dynamic Plasma Biomarkers Reveal Multifaceted Effects of Lecanemab in Early Alzheimer’s Disease https://news.medxy.ai/zh/diabetes-vessel-reconstruction/Medxy AIzh2026-09-29T10:00:52-07:00下肢动脉与冠状动脉血运重建中的糖尿病病程及晚期并发症差异：一项比较性综述 https://news.medxy.ai/ja/diabetes-complications-comparison/Medxy AIja2026-09-29T10:00:32-07:00下肢動脈疾患と冠動脈疾患における糖尿病罹病期間・高度合併症の比較：血行再建をめぐる総説 https://news.medxy.ai/vi/diabetes-complications-comparison-2/Medxy AIvi2026-09-29T10:00:09-07:00Thời gian mắc đái tháo đường và các biến chứng đái tháo đường tiến triển ở tái thông mạch chi dưới so với tái thông mạch vành: Tổng quan so sánh https://news.medxy.ai/diabetes-duration-and-advanced-diabetes-related-complications-in-lower-extremity-versus-coronary-revascularization-a-comparative-review/Medxy AIen2026-09-29T09:59:47-07:00Diabetes Duration and Advanced Diabetes-Related Complications in Lower-Extremity Versus Coronary Revascularization: A Comparative Review https://news.medxy.ai/zh/automated-insulin-delivery-5/Medxy AIzh2026-09-29T09:58:53-07:00弥合空白：推进1型糖尿病孕妇的自动化胰岛素输注技术发展 https://news.medxy.ai/ja/automated-insulin-pregnancy/Medxy AIja2026-09-29T09:58:34-07:00妊娠中の1型糖尿病に対する自動インスリン投与の進化：医療の空白を埋める https://news.medxy.ai/vi/insulin-automation-pregnancy/Medxy AIvi2026-09-29T09:58:13-07:00Thu hẹp khoảng cách: thúc đẩy tự động đưa insulin cho phụ nữ mang thai mắc đái tháo đường type 1 https://news.medxy.ai/bridging-the-gap-advancing-automated-insulin-delivery-for-pregnant-women-with-type-1-diabetes/Medxy AIen2026-09-29T09:57:52-07:00Bridging the Gap: Advancing Automated Insulin Delivery for Pregnant Women with Type 1 Diabetes